The global lung cancer screening software market size is projected to reach USD 45.0 million by 2030, growing at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2030, according to a new report published by Grand View Research, Inc. This steady market growth is primarily attributed to the increasing global incidence of lung cancer as well as the expanding implementation of...